TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36681456.
- Also identified by DOI 10.1016/j.kint.2022.10.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aspirin effectively prevents subsequent cardiovascular events. A post hoc subgroup analysis of the International Polycap Study 3 (TIPS-3) trial suggests that patients with chronic kidney disease might also benefit from aspirin for primary prevention. We consider the merits of doing so in practice.
Medical subject headings
- Cardiovascular Diseases
- Renal Insufficiency, Chronic